- The Central Government on March 27, 2019 has approved the continuation of the Biomedical Research Career Programme (BRCP), and Wellcome Trust (WT) / DBT India Alliance beyond its initial 10-year term (2008-09 to 2018-29) to a new five year phase (2019-20 to 2023-24) with Department of Biotechnology (DBT) increasing its commitment to two times that of WT.
- The total financial implication will be Rs. 1092 crore with DBT and WT contributing Rs.728 crore and Rs.364 crore respectively.
Achievements
- Over its 10 years of funding in a 1:1 partnership, the Programme has fulfilled its objectives of building and nurturing talent of highest global standards in cutting-edge biomedical research in India, which has led to important scientific breakthroughs and applications to meet societal needs.
- BRCP has made it attractive for high quality Indian scientists working abroad to return to India, and has increased the number of locations geographically within India where world-class biomedical research is undertaken.
- In the extending phase, the Programme would continue to build this capacity as also strengthen clinical research and work towards addressing important health challenges for India.
- Continuation of the Programme with increased stake from the Government of India is important to bring about these returns.
